Atossa Therapeutics(@atossainc) 's Twitter Profile Photo

Atossa Therapeutics and Quantum Leap Healthcare today announced the initiation of a new study to evaluate (Z)-endoxifenin combination with abemaciclib (VERZENIO®) in women with ER+/HER2- breast cancer.

Learn more: investors.atossatherapeutics.com/news-releases/…

$ATOS

Atossa Therapeutics and Quantum Leap Healthcare today announced the initiation of a new study to evaluate (Z)-endoxifenin combination with abemaciclib (VERZENIO®) in women with ER+/HER2- breast cancer.

Learn more: investors.atossatherapeutics.com/news-releases/… 

$ATOS #clinicaltrial #breastcancer
account_circle
carolynjack(@carolynjack) 's Twitter Profile Photo

Shiela Appavoo MD⁩ underscored the inequity created by outdated ⁦CTFPHC | GECSSP⁩ guidelines. Black, , and other racialized women tend to get in their 40s. But Cdn guidelines don’t recommend screening until age 50.

⁦@ShielaAppavoo⁩ underscored the inequity created by outdated ⁦@cantaskforce⁩ guidelines. Black, #SouthAsian, #Indigenous and other racialized women tend to get #breastcancer in their 40s. But Cdn guidelines don’t recommend screening until age 50. #unfair
account_circle
Dr. Ariella Hanker(@AriellaHanker) 's Twitter Profile Photo

🔥Check out this paper from the Chan Lab Isaac Chan, MD, PhD in Cell Reports Medicine
➡️single cell seq data to define and predict immune cell interactions in
➡️the InteractPrint score predicts response to
UTSW Simmons Cancer Center
doi.org/10.1016/j.xcrm…

🔥Check out this paper from the Chan Lab @ithinkichan in @CellRepMed
➡️single cell seq data to define #IntratumorHeterogeneity and predict immune cell interactions in #BreastCancer
➡️the InteractPrint score predicts response to #immunotherapy 
@utswcancer 
doi.org/10.1016/j.xcrm…
account_circle
Atossa Therapeutics(@atossainc) 's Twitter Profile Photo

📅 Mark your calendars! Atossa Therapeutics’ CEO, Dr Steven Quay, will present at the Noble Capital Markets Emerging Growth Healthcare Conference on April 17 at 9 AM ET. Join us virtually to discover the latest in treatment. Register now: bit.ly/3xDCTVD

$ATOS

📅 Mark your calendars! Atossa Therapeutics’ CEO, @quay_dr, will present at the Noble Capital Markets Emerging Growth Healthcare Conference on April 17 at 9 AM ET. Join us virtually to discover the latest in #BreastCancer treatment. Register now: bit.ly/3xDCTVD 

$ATOS
account_circle